IRCT20120215009014N516尚未招募3 期
Effect of discontinuing immune-modulating drugs versus control group on prognosis in patients with relapsing-remitting multiple sclerosis: a single-blind randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 178
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55 years 至 80 years(—)
- 性别
- All
入选标准
- •Age 55 to 80 years
- •Relapsing-remitting multiple sclerosis
- •Taking drugs that modulate the immune system
排除标准
- •Disease attack in the last 5 years
- •Taking Tysabri or Fingolimod drugs
研究者
相似试验
已完成
不适用
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in immune mediated inflammatory disease (IMID) patients, with special attention for COVID-19Immune mediated inflammatory diseasesautoimmune diseases100179691000381610023213NL-OMON54899Sint Maartenskliniek2,200
已完成
4 期
COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial<p>Rheumatoid arthritis<br />Psoriatic arthritis<br />Axial spondyloarthritis<br />Immune mediated inflammatory diseases<br />Inflammatory rheumatic diseases</p>10003816NL-OMON22848Sint Maartenskliniek2,200
招募中
1 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trialANCA vasculitis, End-stage Renal diseaseCTIS2024-512470-10-00Centre Hospitalier Departemental Vendee136
招募中
4 期
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, randomized, open-label, clinical trial2024-512470-10-00Centre Hospitalier Departemental Vendee136
进行中(未招募)
不适用
Evaluation de l’arrêt du traitement immunosuppresseur d’entretien après 2 ans dans les glomérulonéphrites lupiques prolifératives - etude WIN LUPUSEUCTR2010-022859-30-FRASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
